Marrone Bio Innovations Inc (MBII) investors sentiment decreased to 0.57 in 2017 Q4. It’s down -0.21, from 0.78 in 2017Q3. The ratio turned negative, as 4 hedge funds increased or opened new holdings, while 7 cut down and sold their equity positions in Marrone Bio Innovations Inc. The hedge funds in our database now have: 11.74 million shares, down from 11.77 million shares in 2017Q3. Also, the number of hedge funds holding Marrone Bio Innovations Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 2 Increased: 2 New Position: 2.
Lafayette Investments Inc decreased Walt Disney Holding Co (DIS) stake by 28.32% reported in 2017Q4 SEC filing. Lafayette Investments Inc sold 14,159 shares as Walt Disney Holding Co (DIS)’s stock declined 8.57%. The Lafayette Investments Inc holds 35,834 shares with $3.85M value, down from 49,993 last quarter. Walt Disney Holding Co now has $150.46 billion valuation. The stock decreased 0.18% or $0.18 during the last trading session, reaching $100.06. About 2.54M shares traded. The Walt Disney Company (NYSE:DIS) has declined 11.59% since April 23, 2017 and is downtrending. It has underperformed by 23.14% the S&P500.
Among 39 analysts covering The Walt Disney Company (NYSE:DIS), 24 have Buy rating, 2 Sell and 13 Hold. Therefore 62% are positive. The Walt Disney Company had 154 analyst reports since July 24, 2015 according to SRatingsIntel. On Thursday, January 12 the stock rating was downgraded by Pivotal Research to “Sell”. The stock of The Walt Disney Company (NYSE:DIS) earned “Hold” rating by Needham on Wednesday, April 26. As per Monday, October 16, the company rating was maintained by BMO Capital Markets. The company was upgraded on Monday, January 30 by Morgan Stanley. The company was upgraded on Tuesday, January 2 by Macquarie Research. Piper Jaffray maintained The Walt Disney Company (NYSE:DIS) on Wednesday, November 22 with “Buy” rating. The rating was maintained by Needham with “Hold” on Thursday, September 7. Morgan Stanley maintained The Walt Disney Company (NYSE:DIS) on Thursday, April 20 with “Overweight” rating. The firm has “Hold” rating by Jefferies given on Monday, September 11. The stock of The Walt Disney Company (NYSE:DIS) has “Buy” rating given on Monday, June 12 by RBC Capital Markets.
Since February 26, 2018, it had 0 insider buys, and 1 sale for $194,780 activity. 1,797 The Walt Disney Company (NYSE:DIS) shares with value of $194,780 were sold by LEWIS AYLWIN B.
Investors sentiment increased to 0.9 in 2017 Q4. Its up 0.01, from 0.89 in 2017Q3. It improved, as 58 investors sold DIS shares while 690 reduced holdings. 162 funds opened positions while 508 raised stakes. 896.07 million shares or 0.31% less from 898.84 million shares in 2017Q3 were reported. Stifel Financial Corporation owns 834,600 shares. Jacobs & Ca invested 1.75% in The Walt Disney Company (NYSE:DIS). 30,894 are owned by Willingdon Wealth. 4,645 are held by Horizon Kinetics Limited Liability Company. Wealthfront owns 58,561 shares for 0.07% of their portfolio. Valley Natl Advisers Incorporated owns 6,292 shares. Etrade Cap Mgmt Limited Liability Corp invested in 22,174 shares or 0.08% of the stock. Moreover, Botty Invsts Ltd has 0.05% invested in The Walt Disney Company (NYSE:DIS) for 1,575 shares. Cayman Islands-based Quantres Asset Management Limited has invested 1.44% in The Walt Disney Company (NYSE:DIS). Bright Rock Cap Lc reported 0.73% of its portfolio in The Walt Disney Company (NYSE:DIS). Acadian Asset Mngmt Ltd Liability Com, Massachusetts-based fund reported 3.03M shares. Chartist Inc Ca has 0.12% invested in The Walt Disney Company (NYSE:DIS). Zurcher Kantonalbank (Zurich Cantonalbank) reported 0.36% of its portfolio in The Walt Disney Company (NYSE:DIS). Private Asset Mgmt holds 1.3% or 76,258 shares. Glenmede Company Na owns 367,518 shares.
Analysts await The Walt Disney Company (NYSE:DIS) to report earnings on May, 8 after the close. They expect $1.68 earnings per share, up 12.00% or $0.18 from last year’s $1.5 per share. DIS’s profit will be $2.53B for 14.89 P/E if the $1.68 EPS becomes a reality. After $1.89 actual earnings per share reported by The Walt Disney Company for the previous quarter, Wall Street now forecasts -11.11% negative EPS growth.
Since January 1, 0001, it had 1 buying transaction, and 0 sales for $5.00 million activity.
Marrone Bio Innovations, Inc. provides bio pest management and plant health products primarily for agricultural and water markets in the United States and internationally. The company has market cap of $172.54 million. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. It currently has negative earnings. The companyÂ’s products include Regalia, a plant extract fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants.
Analysts await Marrone Bio Innovations, Inc. (NASDAQ:MBII) to report earnings on May, 10. They expect $-0.04 earnings per share, up 87.10% or $0.27 from last year’s $-0.31 per share. After $-0.24 actual earnings per share reported by Marrone Bio Innovations, Inc. for the previous quarter, Wall Street now forecasts -83.33% EPS growth.
The stock decreased 0.59% or $0.01 during the last trading session, reaching $1.69. About 322,658 shares traded. Marrone Bio Innovations, Inc. (MBII) has risen 33.33% since April 23, 2017 and is uptrending. It has outperformed by 21.78% the S&P500.